Bain Capital Life Sciences Investors, LLC Cabaletta Bio, Inc. Put Options Transaction History
Bain Capital Life Sciences Investors, LLC
- $298 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CABA
# of Institutions
86Shares Held
43MCall Options Held
154KPut Options Held
192K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$11.7 Million0.02% of portfolio
-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$6.33 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$5.28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.45MShares$4.59 Million0.0% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...